NCT00367861View on ClinicalTrials.gov

Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance

PHASE3CompletedINTERVENTIONAL

Enrollment

564

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 30, 2012

Study Completion Date

May 31, 2013

Conditions

SarcomaGastro-intestinal Stromal Tumors (GIST)

Interventions

DRUG

interruption of Glivec®

Trial Locations (8)

13000

Hopitaux de La Timone, Marseille

Institut Paoli Calmette, Marseille

33000

Institut Bergonié, Bordeaux

57000

Centre Alexis Vautrin, Nancy

59000

Centre Oscar Lambret, Lille

69008

Centre Leon Berard, Lyon

Hopital Edouard Herriot, Lyon

94850

Institut Gustave Roussy, Villejuif

All Listed Sponsors

collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

lead

Centre Leon Berard

OTHER

NCT00367861 - Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | Biotech Hunter | Biotech Hunter